LVGI Stock | News | Quote | Stock Forum | Friday, October 25,

New Post Public Reply Private Reply Replies (0) Message Board

Oct 25, 2013 at 3:20 PM

Limitless Venture Group Inc. LVGI Company Overview

Stock Message Board http://investorshangout.com/search?q=LVGI&...mp;yt1=Go!

Last Updated: Friday, October 25, 2013 3:20:25 PM

Limitless Venture Group Inc. LVGI Current Price and Quotes
Last Price 0.0018
Previous Close 0.0017 Open 0.0018
Daily Range 0.0021 - 0.0015 52wk Range 1.25 - 0.0012
Volume 68,478,272 Dividend N/A
Average Vol (3m) 18,479,780 Yield N/A
Limitless Venture Group Inc. LVGI

Company Verified Profile
Company Information

836 Grundy Avenue
Holbrook, NY 11741

Website: http://www.lvginc.com
Phone: 631-750-3195
Email: info@lvginc.com

Limitless Venture Group Inc. LVGI
Limitless Venture Group, Inc. (LVGI) known as THE BRAND BUILDERS is a development stage company dedicated to the production, distribution and marketing of unique, quality product lines. LVGI acts as a brand incubator bringing products from concept to reality then releasing them as stand alone companies. LVGI is a full service brand development company with an in house Bio-Chemical engineering and formulations department, in-house brand identity team, full graphics department as well as an exper...

Limitless Venture Group Inc. LVGI
Financial Reportings and Disclosures

Reporting Status Alternative Reporting Standard
Deregistered a/o May 29, 2007
Audited Financials Unaudited
Latest Report Jun 30, 2013 Annual Report
CIK 0000874993
Fiscal Year End 6/30
OTC Marketplace OTC Pink Current
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o May 29, 2012
Incorporated In: NV, USA
Year of Inc. 2007
Employees 5 a/o May 29, 2012
Company Officers/Contacts

Peter Scalise III CEO, President
Richard Hall EVP, Prod & Creative Svcs.
Company Directors

William Balcuk
Patrick Walsh
Company Notes

Formerly=EnerBrite Technologies Group, Inc. until 2-2013
Formerly=Compliance Resource Group, Inc. until 6-07
Formerly=IDF International, Inc. until 2-07
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Law Office of William G. Goode
20 Peachtree Ct.
Holbrook, NY, 11741
United States

Investor Relations Firm
Not Available

Limitless Venture Group Inc. LVGI
LVGI Security Details

Share Structure

Market Value1 $618,624 a/o Oct 24, 2013
Shares Outstanding 363,896,632 a/o Oct 24, 2013
Float 353,896,632 a/o Oct 24, 2013
Authorized Shares 2,500,000,000 a/o Oct 24, 2013
Par Value Not Available
Shareholders

Shareholders of Record 105 a/o Jun 04, 2013
Security Notes

New Issue=8-91 200,000 Units (1 sh Com & 1 Warr ) at $5 per Unit
Capital Change=shs decreased by 1 for 100 split. Rec date=6-28-07. Pay date=2-15-07
Capital Change=shs decreased by 1 for 1000 split Pay date=09/21/2007.
Capital Change=shs decreased by 1 for 100000 split Pay date=11/10/2008.
Capital Change=shs decreased by 1 for 1000 split. Ex-date=02/04/2013.
Short Selling Data

Short Interest 126,800 (100%)
Sep 30, 2013
Significant Failures to Deliver No
Transfer Agent(s)

Olde Monmouth Stock Transfer Co., Inc.

Limitless Venture Group Inc. LVGI Financials
Period Ending Jun 30, 2013 Jun 30, 2012
Total Revenue - -
Cost of Revenue - -
Gross Profit - -
Operating Expenses

Research and Development - -
Sales, General and Admin. 10,062 1
Non-Recurring Items - -
Other 96 -
Operating Income (10,158) (1)
Income From Continuing Operations

Add'l Income/Expense Items - (3,849)
Earnings Before Interest and Tax (10,158) (3,850)
Interest Expense 132 -
Earnings Before Tax (10,290) (3,850)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (10,290) (3,850)
Non Recurring Events

Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (10,290) (3,850)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (10,290) (3,850)

Limitless Venture Group Inc. LVGI Recent News

Oct 9, 2013 Two International Federation of Body Building (IFBB) Pros Join Limitless Venture Group's Genetically Enhanced Anabolic Research Inc. (G.E.A.R.) Sports Nutraceuticals Subsidiary Team
Oct 8, 2013 Limitless Venture Group's Genetically Enhanced Anabolic Research Inc. (G.E.A.R.) Sports Nutraceuticals Subsidiary Has an Amazing Kickoff at Joe Weider's Olympia Weekend 2013
Sep 19, 2013 Liz Gaspari, The Most Powerful Woman In The Sports Nutrition World, Poised To Take Over The Male Dominated Sports Supplement Industry On December 1, 2013 Named President Of Limitless Venture Group Inc's G.E.A.R. Sports Nutraceutical Subsidiary
Sep 19, 2013 Liz Gaspari, The Most Powerful Woman In The Sports Nutrition World, Poised To Take Over The Male Dominated Sports Supplement Industry On December 1, 2013 Named President Of Limitless Venture Group Incs G.E.A.R. Sports Nutraceutical Subsidiary
Sep 18, 2013 Limitless Venture Group's Genetically Enhanced Anabolic Research Inc. (G.E.A.R.) Sports Nutraceuticals Subsidiary Signs Letter of Intent for Distribution Agreement With Australia's Largest Supplement Retailer/Wholesaler
Sep 16, 2013 Limitless Venture Group Inc. Addresses Shareholder Concerns Regarding Recent Common Stock Trading
Sep 5, 2013 Limitless Venture Group's Genetically Enhanced Anabolic Research Inc. (G.E.A.R.) Sports Nutraceuticals Subsidiary Inks Advertising Agreement With Leading Sport and Fitness Magazine
Sep 4, 2013 Limitless Venture Group Inc. Officially Signs Pete Maletto, World Class Formulator, as Director of Product Development for LVGI's G.E.A.R. Sports Nutraceutical Subsidiary
Aug 14, 2013 Former UFC Light Heavyweight Champion Mauricio "SHOGUN" Rua to Wear Limitless Venture Group's Genetically Enhanced Anabolic Research Inc. (G.E.A.R.(TM)) Sports Nutraceuticals Subsidiary Colors in His Nationally Televised Match August 17
Jul 26, 2013 Limitless Venture Group Lands Another Body Building Icon and International Federation of Body Building (IFBB) Pro for a Senior Management Position for Its Genetically Enhanced Anabolic Research Inc. (G.E.A.R.(TM)) Sports Nutraceuticals Subsidiary

LVGI Limitless Venture Group Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=LVGI&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/LVGI/quote
Stock Chart http://www.otcmarkets.com/stock/LVGI/chart
Company Info http://www.otcmarkets.com/stock/LVGI/company-info
Recent News http://www.otcmarkets.com/stock/LVGI/news
Financials http://www.otcmarkets.com/stock/LVGI/financials
Filings and Disclosure http://www.otcmarkets.com/stock/LVGI/filings
Short Sales http://www.otcmarkets.com/stock/LVGI/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/LVGI/insider-transactions
Research Reports http://www.otcmarkets.com/stock/LVGI/research
Summary http://finance.yahoo.com/q?s=LVGI
Historical Prices http://finance.yahoo.com/q/hp?s=LVGI+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=LVGI
Basic Chart http://finance.yahoo.com/q/bc?s=LVGI+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=LVGI+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=LVGI+Headlines
Press Releases http://finance.yahoo.com/q/p?s=LVGI+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=LVGI+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=LVGI+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=LVGI+Industry
Major Holders http://finance.yahoo.com/q/mh?s=LVGI+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=LVGI+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=LVGI+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=LVGI
Balance Sheet http://finance.yahoo.com/q/bs?s=LVGI
Cash Flow http://finance.yahoo.com/q/cf?s=LVGI+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/LVGI
Market Watch http://www.marketwatch.com/investing/stock/LVGI
Bloomberg http://www.bloomberg.com/quote/LVGI:US
Morningstar http://quotes.morningstar.com/stock/s?t=LVGI
Bussinessweek http://investing.businessweek.com/research/st...icker=LVGI
Barchart http://www.barchart.com/quotes/stocks/LVGI
OTC Short Report http://otcshortreport.com/index.php?index=LVGI
Investopedia http://www.investopedia.com/markets/stocks/LVGI/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Allergan Aesthetics Study Shows Rising Patient Satisfaction

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

TCL's Display Future: AI Meets Screens at DTC 2026

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Novo's Semaglutide Shows Promise in MASH Study

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Innovent's SINTBILO® Hits Primary Endpoint in Study

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Stavian Group Eyes AI-Driven Southeast Asia Growth

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

GlycoNex Eyes Japanese Market with Denosumab Biosimilar

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...